Drugs / BI 44847
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT02211950 | Oct → Dec 2008 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02211924 | Aug → Sep 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT00558909 | Jun → Nov 2007 | type 2 diabetes mellitus | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02211963 | Feb → Jun 2007 | type 2 diabetes mellitus | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02209844 | Aug 2006 → Jan 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02211937 Comparator | Jan → Mar 2007 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 44847 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02211937 ↗ |
| Route | Oral | “following oral administration” NCT00558909 ↗ |